Use of Innovative Multi-Omics
Platforms to Study Neurodegenerative Disease
Kerry Shea1,3, Lucy, Frost1, TJ Allen1, Eleanor Platt1, Irma O’Meara1, Ana-Maria Nastase1, Tara Bowen1, Maike Langini1, Régine Anderson1, Caitlin Shaw1, Paul Sharp1, Jim McCarthy2, Donna Finch2, Gayle Marshall1
1 Medicines Discovery Catapult, Alderley Park, Cheshire, SK10 4ZF, UK; 2 Alchemab Therapeutics, Whittlesford, Cambridgeshire, CB22 4WL, UK.
3 Corresponding Author: info@md.catapult.org.uk
Abstract
This
Clinical Samples
BulkAnalysis
Pre-Clinical Samples
SpatialAnalysis
